XML 23 R12.htm IDEA: XBRL DOCUMENT v3.23.1
MARKETABLE SECURITIES
3 Months Ended
Mar. 31, 2023
MARKETABLE SECURITIES  
MARKETABLE SECURITIES

5. MARKETABLE SECURITIES:

Amortized cost and estimated fair market value of marketable securities classified as available-for-sale (excluding cash equivalents) at March 31, 2023, were as follows:

Amortized

Gross Unrealized

Estimated Fair

(In thousands)

    

Cost

    

Gains

    

Losses

    

Market Value

Investments due in 3 months or less:

 

  

 

  

 

  

 

  

Corporate securities

$

72,749

$

$

(348)

$

72,401

Total

 

72,749

 

 

(348)

 

72,401

Investments due in 4-12 months:

 

  

 

  

 

  

 

  

Corporate securities

 

111,179

 

 

(2,375)

 

108,804

Total

 

111,179

 

 

(2,375)

 

108,804

Investments due in 12 months or greater:

 

  

 

  

 

  

 

  

Corporate securities

 

83,662

 

324

 

(752)

 

83,234

Total

83,662

 

324

(752)

 

83,234

Total marketable securities

$

267,590

$

324

$

(3,475)

$

264,439

Accrued interest receivable was $1.7 million at March 31, 2023 and was recorded within prepaid expenses and other current assets on the condensed consolidated balance sheet.

Amortized cost and estimated fair market value of marketable securities classified as available-for-sale (excluding cash equivalents) at December 31, 2022, were as follows:

Amortized

Gross Unrealized

Estimated Fair

(In thousands)

    

Cost

    

Gains

    

Losses

    

Market Value

Investments due in 3 months or less:

 

  

 

  

 

  

 

  

Corporate securities

$

21,803

$

$

(135)

$

21,668

Total

 

21,803

 

 

(135)

 

21,668

Investments due in 4-12 months:

 

  

 

  

 

  

 

  

Corporate securities

 

173,833

 

 

(4,019)

 

169,814

Total

 

173,833

 

 

(4,019)

 

169,814

Investments due in 12 months or greater:

 

  

 

  

 

  

 

  

Corporate securities

58,128

 

71

 

(1,240)

 

56,959

Total

 

58,128

 

71

 

(1,240)

 

56,959

Total marketable securities

$

253,764

$

71

$

(5,394)

$

248,441

Accrued interest receivable was $1.2 million at December 31, 2022 and was recorded within prepaid expenses and other current assets on the condensed consolidated balance sheet.

The following table summarizes marketable securities classified as available-for-sale (excluding cash equivalents) in a continuous unrealized loss position for which an allowance for credit losses was not recorded at March 31, 2023:

Less Than 12 Months

12 Months or Longer

Total

    

Estimated

    

Gross

    

Estimated

    

Gross

    

Estimated

    

Gross

Fair Market

Unrealized

Fair Market

Unrealized

Fair Market

Unrealized

(In thousands)

Value

Losses

Value

Losses

Value

Losses

Corporate securities

$

36,014

$

(288)

$

175,733

$

(3,187)

$

211,747

$

(3,475)

Total marketable securities

$

36,014

$

(288)

$

175,733

$

(3,187)

$

211,747

$

(3,475)

In the three months ended March 31, 2023 and 2022, no unrealized losses on marketable securities were recognized in income.

The Company does not intend to sell and it is unlikely that it will be required to sell the securities prior to their anticipated recovery. The issuers are high quality (investment grade) and the decline in fair value is largely due to changes in interest rates. Additionally, the issuers continue to make timely interest payments on the marketable securities with the fair value expected to recover as they reach maturity.